Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

46 Stocks Moving In Thursday's Mid-Day Session

Gainers Indonesia Energy Corporation Limited (NASDAQ: INDO) shares jumped 158.2% to $7.23 after tumbling 18% on Wednesday. Indonesia Energy said it projects to commence drilling of 2 back-to-back new wells within 30 days and a third by mid-year.

Benzinga

GitLab Shares Gain After JPMorgan Upgrade, Thanks To Microsoft & ServiceNow

JPMorgan analyst Sterling Auty upgraded GitLab Inc (NASDAQ:GTLB) to Overweight from Neutral with an unchanged price target of $99, suggesting an upside of 62%. The analyst calls the company a "Growth All-Star" with a current valuation of less than 18-times 2022 revenue. The results from Microsoft Corp (NASDAQ:MSFT) and ServiceNow Inc (NYSE:NOW) validate that the fundamentals in software continue…

Benzinga

Mid-Morning Market Update: US Markets Open Higher As GDP Rises 6.9% In Fourth Quarter

US stocks opened on a strong note on Thursday after the country’s economy grew 6.9% on quarter during the last three months of previous year, up from 2.3% expansion in the prior quarter and also above market estimates of 5.5%.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Benzinga's Top Ratings Upgrades, Downgrades For January 27, 2022

Upgrades

Benzinga

Direct Digital Holdings To Start Trading Tomorrow

DIRECT DIGITAL HOLDINGS, INC (NASDAQ:DRCT) IPO will take place January, 28 on the NASDAQ exchange under the ticker DRCT. The company is offering shares at an expected price between $7.00 and $9.00 per share with an insider lock-up period of 180 days ending on July 27, 2022.

Benzinga

Fujifilm To Buy Cell Therapy Plant From Atara For $100M

FUJIFILM Diosynth Biotechnologies, a subsidiary of FUJIFILM Corporation, will acquire a cell therapy plant from Atara Biotherapeutics Inc (NASDAQ: ATRA)

Benzinga

Sierra Oncology Raises $135M Via Equity To Fund Lead Program Development

Sierra Oncology Inc (NASDAQ: SRRA) has priced its underwritten public offering of 4.07 million shares at $27 per share and the pre-funded warrants at $26.999 per pre-funded warrant.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Jim Cramer Shares His Thoughts On ArcBest, Ulta Beauty And More

On CNBC’s "Mad Money Lightning Round," Jim Cramer said he likes ArcBest Corporation (NASDAQ: ARCB).

Benzinga

The Daily Biotech Pulse: Galapagos Appoints J&J Exec As CEO, Aridis Gets Funding For Antiviral Treatment, Moderna Starts Omicron-Specific Booster Study

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

26 Stocks Moving in Thursday's Pre-Market Session

Gainers

Benzinga

China Conditionally Approves AMD-Xilinx Deal: Report

China's market regulator conditionally approved Advanced Micro Devices Inc's (NASDAQ:AMD) $35 billion all-stock deal for peer Xilinx Inc (NASDAQ:XLNX), Reuters reports. Related Content: AMD, Xilinx Stockholders Approve Acquisition In December, the companies stated that conversations with regulators continue to progress productively and expect to secure all required approvals. Xilinx manufactures programmable chips for data centers, telecom including 5G…

Benzinga

iPhone Users May Soon Be Able To Accept Credit Cards Without Any Additional Hardware

Apple Inc (NASDAQ: AAPL) is reportedly working on integrating credit card acceptance directly into the iPhone.

Benzinga

41 Biggest Movers From Yesterday

Gainers Ebang International Holdings Inc. (NASDAQ: EBON) shares gained 35.4% to settle at $1.09 on Wednesday as investors weighed the Federal Reserve Reserve decision to leave rates unchanged.

Benzinga

Why Alibaba And Other Tech Stocks Are Dragging The Hang Seng Index Lower Today

Shares of U.S.-listed Chinese tech companies traded notably lower in Hong Kong on Thursday, dragging the benchmark Hang Seng Index into negative territory.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

12 Consumer Discretionary Stocks Moving In Wednesday's After-Market Session

Gainers Puxin (NYSE:NEW) stock rose 11.6% to $0.2 during Wednesday's after-market session. The market value of their outstanding shares is at $17.9 million.

Benzinga

What To Watch On Tesla's Chart As The EV Leader Heads Into Q4 Earnings

Tesla, Inc (NASDAQ: TSLA) was trading about 4% higher by mid-afternoon on Wednesday following a fairly muted initial reaction to the Federal Reserve releasing its January minutes, when it announced the decision to keep interest rates unchanged for the time being.

Benzinga

Analysts Remain Divided On Verizon Post Q4 Results

Analysts had mixed views on Verizon Communications Inc (NYSE:VZ) post Q4 earnings. Deutsche Bank analyst Bryan Kraft raised the price target on Verizon to $59 from $57 (15% upside) and reiterated a Hold rating on the shares. The analyst sees about 8% upside in the stock over the next 12 months, with the target increasing…

Benzinga

New Energy Lands as Hottest Category Among Chinese Concept Stocks in 2021 – Bamboo Works Special Report

Investors kept a close look at China’s solar and wind power stocks last year, but were least interested in the hobbled education sector By Bamboo Works team

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Existing Agreements Between Microsoft, Activision, Sony Point To 'Call Of Duty' Remaining Multiplatform (For Now)

Microsoft Corporation's (NASDAQ: MSFT) planned acquisition of game developer Activision Blizzard, Inc. (NASDAQ: ATVI) left PlayStation fans feeling left out — or at least wondering if they might

Benzinga

32 Stocks Moving In Wednesday's Mid-Day Session

Gainers Exela Technologies, Inc. (NASDAQ: XELA) rose 32% to $0.7262 after the company announced a share buyback of up to 100 million shares of common stock at $1 per share through an exchange offer of new notes.

Benzinga

Clever Leaves Enters US Consumer CBD Market Via Herbal Brands' JoySol

Clever Leaves Holdings Inc. (NASDAQ: CLVR), a multinational operator and licensed producer of pharmaceutical-grade cannabinoids, announced Wednesday that it has officially entered the U.S. CBD market through the launch of its consumer-oriented CBD line JoySol.

Benzinga

JPMorgan Cuts Plug Power Price Target By $10 Despite Strong Execution

Although Plug Power Inc.’s (NASDAQ: PLUG) stock came under pressure following the Business Update call, the company seems to be “executing well across its business lines,” according to JPMorgan.

Benzinga

Stocks That Hit 52-Week Lows On Wednesday

During Wednesday's morning session, 34 stocks hit new 52-week lows.

Benzinga

What Is Wordle? How To Play The Hottest New Free Puzzle Game Everyone Is Talking About

A new word guessing game is taking over social media mentions and providing bragging rights to those who can successfully complete a once-a-day puzzle.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For January 26, 2022

Upgrades

1 … 850 851 852 853

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.